These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 1306614)
1. [The role of electrochemical techniques in the understanding of the mechanism of drug actions. Example of an anti-Bilharzia agent]. Fleury MB Ann Pharm Fr; 1992; 50(4):183-98. PubMed ID: 1306614 [TBL] [Abstract][Full Text] [Related]
2. Toward an understanding of the schistosomicidal effect of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (oltipraz). Fleury MB; Largeron M; Martens T Biochem Pharmacol; 1991 Feb; 41(3):361-7. PubMed ID: 1994895 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver. Davidson NE; Egner PA; Kensler TW Cancer Res; 1990 Apr; 50(8):2251-5. PubMed ID: 2317812 [TBL] [Abstract][Full Text] [Related]
5. The antischistosomal activity of oltipraz. Bueding E; Dolan P; Leroy JP Res Commun Chem Pathol Pharmacol; 1982 Aug; 37(2):293-303. PubMed ID: 7134632 [TBL] [Abstract][Full Text] [Related]
6. Disposition of 14C-oltipraz in animals. Pharmacokinetics in mice, rats and monkeys. Comparison of the biotransformation in the infected mouse and in the schistosomes. Heusse D; Marlard M; Bredenbac J; Decouvelaere B; Leroy JP; Bieder A; Jumeau H Arzneimittelforschung; 1985; 35(9):1431-6. PubMed ID: 3936507 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of arachidonic acid and iron-induced mitochondrial dysfunction and apoptosis by oltipraz and novel 1,2-dithiole-3-thione congeners. Shin SM; Kim SG Mol Pharmacol; 2009 Jan; 75(1):242-53. PubMed ID: 18945820 [TBL] [Abstract][Full Text] [Related]
8. Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short-term molecular dosimetry. Roebuck BD; Liu YL; Rogers AE; Groopman JD; Kensler TW Cancer Res; 1991 Oct; 51(20):5501-6. PubMed ID: 1680553 [TBL] [Abstract][Full Text] [Related]
9. Coordinate induction of glutathione S-transferase alpha, mu, and pi expression in murine liver after a single administration of oltipraz. Clapper ML; Everley LC; Strobel LA; Townsend AJ; Engstrom PF Mol Pharmacol; 1994 Mar; 45(3):469-74. PubMed ID: 7511779 [TBL] [Abstract][Full Text] [Related]
10. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones. Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and schistosomicidal activity of 4-methyl-5-(aryl vinyl)-1,2-dithiole-3-thiones. Abdaly F; Vaccher C; Berthelot P; Debaert M; Luyckx M; Deblock S Farmaco; 1991 Jan; 46(1):63-73. PubMed ID: 2054042 [TBL] [Abstract][Full Text] [Related]
12. Protection of retinal pigment epithelial cells from oxidative damage by oltipraz, a cancer chemopreventive agent. Nelson KC; Armstrong JS; Moriarty S; Cai J; Wu MW; Sternberg P; Jones DP Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3550-4. PubMed ID: 12407167 [TBL] [Abstract][Full Text] [Related]
13. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases. Primiano T; Egner PA; Sutter TR; Kelloff GJ; Roebuck BD; Kensler TW Cancer Res; 1995 Oct; 55(19):4319-24. PubMed ID: 7671242 [TBL] [Abstract][Full Text] [Related]
14. Chemopreventive activity of oltipraz. Clapper ML Pharmacol Ther; 1998 Apr; 78(1):17-27. PubMed ID: 9593327 [TBL] [Abstract][Full Text] [Related]
15. Chemopreventive effect of oltipraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F344 rats. Rao CV; Rivenson A; Katiwalla M; Kelloff GJ; Reddy BS Cancer Res; 1993 Jun; 53(11):2502-6. PubMed ID: 8495412 [TBL] [Abstract][Full Text] [Related]
16. Cell-based studies reveal differences in glutathione S-transferase induction between oltipraz and tert-butylhydroquinone. Lamb JG; Franklin MR J Biochem Mol Toxicol; 2002; 16(4):154-61. PubMed ID: 12242683 [TBL] [Abstract][Full Text] [Related]
17. Cancer chemoprotection by oltipraz: experimental and clinical considerations. Helzlsouer KJ; Kensler TW Prev Med; 1993 Sep; 22(5):783-95. PubMed ID: 8234218 [TBL] [Abstract][Full Text] [Related]
18. Stability, blood partition and protein binding of an antifibrotic agent, oltipraz. Bu SC; Kim EJ; Kim SH; Kim SG; Lee MG Res Commun Mol Pathol Pharmacol; 2001; 109(5-6):333-44. PubMed ID: 12889516 [TBL] [Abstract][Full Text] [Related]
19. Inactivation of human immunodeficiency virus type 1 reverse transcriptase by oltipraz: evidence for the formation of a stable adduct. Chavan SJ; Bornmann WG; Flexner C; Prochaska HJ Arch Biochem Biophys; 1995 Dec; 324(1):143-52. PubMed ID: 7503549 [TBL] [Abstract][Full Text] [Related]
20. Chronic daily low dose of 4-methyl-5-(2-pyrazinyl)-1,2-dithiole-3-thione (Oltipraz) in patients with previously resected colon polyps and first degree female relatives of breast cancer patients. Benson AB; Olopade OI; Ratain MJ; Rademaker A; Mobarhan S; Stucky-Marshall L; French S; Dolan ME Clin Cancer Res; 2000 Oct; 6(10):3870-7. PubMed ID: 11051232 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]